Cannabis Vs. Coca-Cola And Marlboro: Marijuana Market Growth Outpaces Alcohol, Tobacco And CPG Giants

Recent financial data from Beacon Securities compares key financial metrics across the alcohol, tobacco and cannabis industries, showing that cannabis is set to outpace major players like Coca-Cola KO, Marlboro MO, and Budweiser BUD in market growth.

Financial Metrics

The EV/Sales ratio, which compares a company’s total value, including debt to its annual sales helps investors see the cost per dollar of sales. A lower EV/Sales ratio suggests a company might be undervalued, indicating a potential investment opportunity, while a higher ratio could imply overvaluation.

Beacon’s report shows the EV/Sales ratios for 2024 and 2025 as follows:

  • Alcohol: 3.6x and 3.4x
  • Tobacco: 4.0x and 3.9x
  • Consumer Packaged Goods (CPG): 3.4x and 3.3x
  • Canadian Licensed Producers (LP): 1.4x and 1.1x
  • U.S. Operators: 1.7x and 1.5x

In terms of the EV/EBITDA metric, which compares company value to earnings before interest, taxes, depreciation and amortization, lower numbers indicate better valuation relative to earnings. Here are the projections:

  • Alcohol: 11.0x for 2024 and 10.4x for 2025
  • Tobacco: 7.5x for 2024 and 7.4x for 2025
  • CPG: 15.5x for 2024 and 14.6x for 2025
  • Canadian Licensed Producers (LP): 17.1x for 2024 and 12.9x for 2025
  • U.S. Operators: 8.0x for 2024 and 6.2x for 2025

Growth Prospects

Meanwhile, the 2023-2025 EBITDA Compound Annual Growth Rate (CAGR) reveals differing growth expectations:

  • Alcohol: 6%
  • Tobacco: 1%
  • CPG: 6%
  • Canadian Licensed Producers (LP): 65%
  • U.S. Operators: 42%

This means that the cannabis industry, particularly U.S. operators and Canadian licensed producers, appears to be undervalued compared to the alcohol, tobacco and consumer packaged goods (CPG) sectors. Despite having significantly lower EV/Sales ratios, indicating they are currently valued lower per dollar of sales, cannabis companies show much higher growth potential as reflected in their impressive EBITDA growth rates.

Investors may be overlooking the rapid growth and future profitability of the cannabis sector, which is poised to outpace more established industries. This discrepancy suggests a potential investment opportunity in the cannabis market as its growth trajectory continues to rise.

These investing issues will be a hot topic at the upcoming Benzinga Cannabis Capital Conference in Chicago this Oct. 8-9. Join us to get more insight into what the wave of weed legalization means for the future of investing in the industry. Hear directly from top executives, investors, advocates, and policymakers. Get your tickets now before prices go up by following this link.

Photo: AI-Generated Image. 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorCannabisMarket SummaryNewsGuidanceRetail SalesMarketsAnalyst RatingsGeneralalcoholalcoholic beverage industryBeacon Securities Limitedblue chip stocksCannabis Marketscannabis salescannabis stocksCPG
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.